Latisha Smith-Chase, MD
Undersea and Hyperbaric Medicine · Redding, CANPI 1154349900
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Kerecis Limited at 36.2% of the total. 2025 is the largest year on record at $2,060, 8.6 times the $239 reported in 2019.
Across 108 payments — averaging $42.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$2K
- Organogenesis Inc.$1K
- Lifenet Health$1K
- Smith+Nephew$348
- Stryker$57
- Solventum Corporation$19
- plus $47 from 3 others
What the payments were for
- Travel & lodging$2,42953%
- Food & beverage$2,13747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 11 | $1,654 |
| Organogenesis Inc. | 48 | $1,358 |
| Lifenet Health | 12 | $1,083 |
| Smith+Nephew | 32 | $348 |
| Stryker | 1 | $57 |
| Solventum Corporation | 1 | $19 |
| Urgo Medical North America, LLC | 1 | $18 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Hartmann USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$6,161
- Kerecis GraftGuide$1,540
- TheraGenesis Wound Matrix$884
- PuraPly$413
How this compares
Too few undersea and hyperbaric medicine providers in Californiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 54 | $1,003 |
| Gentamicin Sulfate | 14 | $793 |
| Doxycycline Hyclate | 33 | $597 |
| Ketoconazole | 14 | $573 |
| Mupirocin | 33 | $338 |
| Diclofenac Sodium | 26 | $286 |
| Levofloxacin | 20 | $190 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $177 |
| Ciprofloxacin Hcl | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Redding
- Yoshinobu MifuneMurrieta$2K
- John GambolPlacentia$1K
- Sara SaltzsteinCamp Pendleton$1K
- Caesar AndersonSan Diego$1K
- Sandra HayesCoronado$764
- John MillingtonThousand Oaks$592
- William ToppenSan Diego$239
- John DeaconSanta Barbara$185
- Gary WillardCarlsbad$172
- Kenneth KellySan Diego$82
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.